Immune mediated lung injury in COVID-19
COVID-19 中免疫介导的肺损伤
基本信息
- 批准号:10367945
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAcute Lung InjuryAcute Respiratory Distress SyndromeAcute respiratory infectionAgeAnimal ModelApoptosisBacterial PneumoniaCOVID-19COVID-19 pandemicCardiopulmonaryCell DeathCellsCessation of lifeChronicCoculture TechniquesCollaborationsCoronavirusCoronavirus InfectionsDataDevelopmentDiseaseElderlyEpithelial CellsEquilibriumExposure toFailureFundingGrantHealthHistonesHost DefenseHumanImmuneImmune responseImmunologyImmunotherapyImpairmentIn VitroInfectionInflammationInflammation MediatorsInflammatory ResponseInternationalKnowledgeLeadLeukocytesLiteratureLungLung infectionsMechanical ventilationMediatingMediator of activation proteinMedicalModelingMorbidity - disease rateMouse StrainsMultiple Organ FailureMurine hepatitis virusMusNatural Killer CellsOxygenPathogenesisPathogenicityPathologyPatientsPeptidesPlayPopulationPositioning AttributePublic HealthPulmonary PathologyReportingResearchResearch ProposalsResolutionRiskRisk FactorsRoleSARS-CoV-2 immunitySARS-CoV-2 infectionSevere Acute Respiratory SyndromeTestingVeteransViralVirusVirus DiseasesVirus ReplicationVirus Sheddingaging populationantimicrobialantiviral immunitybasebehavioral phenotypingcomorbiditycytotoxicitydesignextracellularfightingglobal healthimprovedin vivoinfluenza pneumoniainsightlung developmentlung injurymalemilitary veteranmortalityneutrophilnovelnovel therapeuticspathogenpatient populationpreservationpreventrecruitrepairedresponsesevere COVID-19
项目摘要
SARS-CoV-2 and the disease it causes (COVID-19) has emerged as a major global public
health threat in the span of a few months. In particular, SARS-CoV-2 adds to the present
number of acute respiratory infections, including influenza and bacterial pneumonia, which are
endangering the health of our veterans and aging population. In particular, severe COVID-19
disease is characterized by severe lung injury, which results in severely impaired oxygen
delivery and ultimately multiple organ failure and death. Our ongoing research has focused on a
population of white blood cells called neutrophils, which are the most abundant white blood cell
in our body and which have been shown to be a pivotal immune cell that contributes greatly to
lung injury. However, our current medical knowledge is inadequate for understanding what
neutrophils do in the context of viral infection. Although neutrophils are critical for eliminating
many types of infections, they are believed to be a major contributor to the development of lung
injury, and how to balance their beneficial activities with their harmful functions is poorly
understood. Therefore, a better understanding of how neutrophils behavior and phenotype are
altered during severe SARS-CoV-2 and other viral infections would aid in developing novel
therapies to improve their antimicrobial functions, while limiting their injurious effects. The
research we propose in this grant will examine how well neutrophils eliminate SARS-CoV-2
viruses, or if they are an excessively activated population of immune cells recruited to the lung
whose harmful activities outweighs their benefits. We also will test an exciting new treatment
approach developed by our collaborator at UCLA to see if this can block the damaging effects of
neutrophils on lung cells, while blocking viral replication. The results of this 2-year project will
provide insights into the beneficial versus harmful contributions of neutrophils in the
development of severe COVID-19 disease, and potentially identify new therapies to benefit
veterans and other vulnerable patients.
SARS-CoV-2及其引发的疾病(新冠肺炎)已成为全球主要公共卫生组织
在几个月的时间里对健康构成威胁。尤其是SARS-CoV-2,更是雪上加霜
急性呼吸道感染的数量,包括流感和细菌性肺炎,它们是
危及我们退伍军人和老龄化人口的健康。尤其是严酷的新冠肺炎
这种疾病的特征是严重的肺损伤,导致氧气严重受损。
分娩,最终导致多器官衰竭和死亡。我们正在进行的研究集中在
一组被称为中性粒细胞的白血球,它是最丰富的白血球
在我们的身体里,它被证明是一个关键的免疫细胞,对
肺损伤。然而,我们目前的医学知识不足以理解
中性粒细胞在病毒感染的背景下是这样做的。尽管中性粒细胞对消除
许多类型的感染,它们被认为是肺部发育的主要因素
伤害,以及如何平衡它们的有益活动和有害功能
明白了。因此,更好地了解中性粒细胞的行为和表型
在严重的SARS-CoV-2和其他病毒感染期间发生的改变将有助于开发新的
改善它们的抗菌功能,同时限制它们的有害影响的治疗。这个
我们在这项拨款中提出的研究将检验中性粒细胞如何有效地清除SARS-CoV-2
病毒,或者如果它们是被招募到肺部的过度激活的免疫细胞群
他们的有害活动超过了他们的好处。我们还将测试一种令人兴奋的新疗法
我们在加州大学洛杉矶分校的合作者开发的方法,看看这是否可以阻止
肺细胞上的中性粒细胞,同时阻止病毒复制。这个为期两年的项目的结果将是
提供对中性粒细胞的有益贡献和有害贡献的见解
严重新冠肺炎病的发展,并可能找到新的治疗方法使其受益
退伍军人和其他脆弱的病人。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neutrophils drive pulmonary vascular leakage in MHV-1 infection of susceptible A/J mice.
- DOI:10.3389/fimmu.2022.1089064
- 发表时间:2022
- 期刊:
- 影响因子:7.3
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jane C Deng其他文献
Jane C Deng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jane C Deng', 18)}}的其他基金
Neutrophil heterogeneity and function in host defense during pulmonary infection
肺部感染期间中性粒细胞异质性和宿主防御功能
- 批准号:
9974284 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Neutrophil heterogeneity and function in host defense during pulmonary infection
肺部感染期间中性粒细胞的异质性和宿主防御功能
- 批准号:
10266038 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Neutrophil heterogeneity and function in host defense during pulmonary infection
肺部感染期间中性粒细胞的异质性和宿主防御功能
- 批准号:
10645077 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Mechanisms of Impaired Neutrophil Responses in PostInfluenza Bacterial Pneumonia
流感后细菌性肺炎中中性粒细胞反应受损的机制
- 批准号:
9272520 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Mechanisms of impaired neutrophil responses in postinfluenza bacterial pneumonia
流感后细菌性肺炎中性粒细胞反应受损的机制
- 批准号:
8372229 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Mechanisms of impaired neutrophil responses in postinfluenza bacterial pneumonia
流感后细菌性肺炎中性粒细胞反应受损的机制
- 批准号:
8508300 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Mechanisms of impaired neutrophil responses in postinfluenza bacterial pneumonia
流感后细菌性肺炎中性粒细胞反应受损的机制
- 批准号:
8677960 - 财政年份:2012
- 资助金额:
-- - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
-- - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fellowship